{"id":55545,"date":"2026-04-23T17:03:24","date_gmt":"2026-04-23T10:03:24","guid":{"rendered":"https:\/\/www.oucru.org\/?post_type=project&#038;p=55545"},"modified":"2026-04-23T17:47:07","modified_gmt":"2026-04-23T10:47:07","slug":"seadot","status":"publish","type":"project","link":"https:\/\/www.oucru.org\/id\/project\/seadot\/","title":{"rendered":"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT)"},"content":{"rendered":"<p><span class=\"TextRun SCXW211474958 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW211474958 BCX0\">This study is a phase 4 clinical trial testing whether increasing the dose of a medicine called\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW211474958 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW211474958 BCX0\">tafenoquine<\/span><\/span><span class=\"TextRun SCXW211474958 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW211474958 BCX0\">\u00a0can cure\u00a0<\/span><\/span><span class=\"TextRun SCXW211474958 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW211474958 BCX0\">Plasmodium vivax<\/span><\/span><span class=\"TextRun SCXW211474958 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW211474958 BCX0\">\u00a0malaria\u00a0<\/span><span class=\"NormalTextRun SCXW211474958 BCX0\">infection\u00a0<\/span><span class=\"NormalTextRun SCXW211474958 BCX0\">and prevent it from returning in patients across Southeast Asia.\u00a0<\/span><span class=\"NormalTextRun SCXW211474958 BCX0\">Our\u00a0<\/span><span class=\"NormalTextRun AdvancedProofingIssueV2Themed SCXW211474958 BCX0\">ultimate goal<\/span><span class=\"NormalTextRun SCXW211474958 BCX0\">\u00a0is<\/span><span class=\"NormalTextRun SCXW211474958 BCX0\">\u00a0to improve treatment success and reduce malaria relapses in the region.<\/span><\/span><span class=\"EOP SCXW211474958 BCX0\" data-ccp-props=\"{&quot;134233118&quot;:true}\">\u00a0<\/span><\/p>\n","protected":false},"author":42,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"tags":[],"project_category":[189],"class_list":["post-55545","project","type-project","status-publish","hentry","project_category-malaria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oucru.org\/id\/project\/seadot\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU\" \/>\n<meta property=\"og:description\" content=\"This study is a phase 4 clinical trial testing whether increasing the dose of a medicine called\u00a0tafenoquine\u00a0can cure\u00a0Plasmodium vivax\u00a0malaria\u00a0infection\u00a0and prevent it from returning in patients across Southeast Asia.\u00a0Our\u00a0ultimate goal\u00a0is\u00a0to improve [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oucru.org\/id\/project\/seadot\/\" \/>\n<meta property=\"og:site_name\" content=\"OUCRU\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OUCRUVN\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T10:47:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oucru.org\/wp-content\/uploads\/2022\/11\/img-fallback.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@OUCRU_Programme\" \/>\n<meta name=\"twitter:label1\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oucru.org\/id\/project\/seadot\/\",\"url\":\"https:\/\/www.oucru.org\/id\/project\/seadot\/\",\"name\":\"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU\",\"isPartOf\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#website\"},\"datePublished\":\"2026-04-23T10:03:24+00:00\",\"dateModified\":\"2026-04-23T10:47:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oucru.org\/id\/project\/seadot\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oucru.org\/id\/project\/seadot\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oucru.org\/id\/project\/seadot\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oucru.org\/id\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/www.oucru.org\/id\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oucru.org\/id\/#website\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"name\":\"OUCRU\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\"},\"alternateName\":\"Oxford University Clinical Research Unit (OUCRU)\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oucru.org\/id\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\",\"name\":\"Oxford University Clinical Research Unit.\",\"alternateName\":\"OUCRU\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"contentUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"width\":512,\"height\":333,\"caption\":\"Oxford University Clinical Research Unit.\"},\"image\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OUCRUVN\/\",\"https:\/\/x.com\/OUCRU_Programme\",\"https:\/\/www.linkedin.com\/company\/oucru\/\",\"https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oucru.org\/id\/project\/seadot\/","og_locale":"id_ID","og_type":"article","og_title":"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU","og_description":"This study is a phase 4 clinical trial testing whether increasing the dose of a medicine called\u00a0tafenoquine\u00a0can cure\u00a0Plasmodium vivax\u00a0malaria\u00a0infection\u00a0and prevent it from returning in patients across Southeast Asia.\u00a0Our\u00a0ultimate goal\u00a0is\u00a0to improve [&hellip;]","og_url":"https:\/\/www.oucru.org\/id\/project\/seadot\/","og_site_name":"OUCRU","article_publisher":"https:\/\/www.facebook.com\/OUCRUVN\/","article_modified_time":"2026-04-23T10:47:07+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2022\/11\/img-fallback.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@OUCRU_Programme","twitter_misc":{"Estimasi waktu membaca":"1 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.oucru.org\/id\/project\/seadot\/","url":"https:\/\/www.oucru.org\/id\/project\/seadot\/","name":"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT) - OUCRU","isPartOf":{"@id":"https:\/\/www.oucru.org\/id\/#website"},"datePublished":"2026-04-23T10:03:24+00:00","dateModified":"2026-04-23T10:47:07+00:00","breadcrumb":{"@id":"https:\/\/www.oucru.org\/id\/project\/seadot\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oucru.org\/id\/project\/seadot\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.oucru.org\/id\/project\/seadot\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oucru.org\/id\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/www.oucru.org\/id\/project\/"},{"@type":"ListItem","position":3,"name":"Southeast Asia Dose Optimisation of Tafenoquine (SEADOT)"}]},{"@type":"WebSite","@id":"https:\/\/www.oucru.org\/id\/#website","url":"https:\/\/www.oucru.org\/id\/","name":"OUCRU","description":"","publisher":{"@id":"https:\/\/www.oucru.org\/id\/#organization"},"alternateName":"Oxford University Clinical Research Unit (OUCRU)","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oucru.org\/id\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/www.oucru.org\/id\/#organization","name":"Oxford University Clinical Research Unit.","alternateName":"OUCRU","url":"https:\/\/www.oucru.org\/id\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/","url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","contentUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","width":512,"height":333,"caption":"Oxford University Clinical Research Unit."},"image":{"@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OUCRUVN\/","https:\/\/x.com\/OUCRU_Programme","https:\/\/www.linkedin.com\/company\/oucru\/","https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618"]}]}},"_links":{"self":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/project\/55545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/users\/42"}],"wp:attachment":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/media?parent=55545"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/tags?post=55545"},{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/project_category?post=55545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}